Command Palette

Search for a command to run...

Bharat Parenterals Ltd.
1305.25(-1.04%)
1W: -3.35%

Financials

Charts

YoY Net Sales
Operating Margin
EPS Growth

Pros & Cons

POSITIVES
  • Consistent revenue growth over the last three quarters indicates strong demand for products.
  • Improved gross margins reflect better cost management and pricing strategies.
  • Increased operational efficiency leading to higher profit margins compared to previous quarters.
NEGATIVES
  • Rising raw material costs are squeezing profit margins and impacting overall profitability.
  • High debt levels may restrict financial flexibility and increase risk in volatile markets.
  • A slowdown in export markets could affect future growth prospects and revenue diversification.

Quarterly Results Data

FieldTrendSep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25
Revenue
59.8059.8267.8292.5171.6372.26103.98116
Expenses
57.8655.6171.8299.8291.2080.71114.20114.51
Operating Profit
1.944.21-4-7.31-19.57-8.45-10.221.49
Other Income
2.601.262.642.544.202.951.921.06
Interest
0.630.581.132.772.913.333.943.69
Depreciation
1.751.823.879.039.018.768.528.60
Profit Before Tax
4.545.47-1.36-4.77-15.37-5.50-8.302.55
Tax
2.111.831.204.072.152.371.143.42
Net Profit
2.433.64-2.56-8.84-17.52-7.87-9.44-0.87
Eps in Rs
6.076.45-0.62-14.71-27-10-14.40-1.27